We are live on
!
Find out more
FIM
Fernwood Investment Management Portfolio holdings
AUM
$288M
1-Year Est. Return
33.54%
This Fund
S&P 500
This Quarter
Est. Return
-13.62%
1 Year Est. Return
+33.54%
3 Year Est. Return
+83.37%
5 Year Est. Return
+196.85%
10 Year Est. Return
+650.16%
AUM
$155M
AUM Growth
-$34M
(-18%)
Cap. Flow
-$6.4M
Cap. Flow
% of AUM
-4.12%
Top 10 Holdings %
Top 10 Hldgs %
32.97%
Holding
174
New
8
Increased
42
Reduced
64
Closed
29
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
+$2.28M |
| 2 |
DAY
Dayforce
DAY
|
+$1.5M |
| 3 |
MongoDB
MDB
|
+$913K |
| 4 |
Amazon
AMZN
|
+$856K |
| 5 |
Texas Pacific Land
TPL
|
+$801K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
+$993K |
| 2 |
iShares Preferred and Income Securities ETF
PFF
|
+$841K |
| 3 |
Safety Insurance
SAFT
|
+$762K |
| 4 |
SAGE
Sage Therapeutics
SAGE
|
+$683K |
| 5 |
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
|
+$645K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.27% |
| 2 | Energy | 7.45% |
| 3 | Consumer Discretionary | 6.24% |
| 4 | Technology | 5.76% |
| 5 | Consumer Staples | 5.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GBT
1
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $14.7M | 9.45% |
357,212
-26,490
| -7% | -$993K |
|
|
MYOK
2
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $6.91M | 4.46% |
141,511
-11,620
| -8% | -$640K |
|
|
PTLA
3
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $6.64M | 4.28% |
340,263
+110,885
| +48% | +$2.28M |
|
4
iShares Core S&P 500 ETF
IVV
$884B
| $4.86M | 3.13% |
19,321
-167
| -0.9% | -$45.4K |
|
5
Altria Group
MO
$114B
| $3.53M | 2.27% |
71,417
-397
| -0.6% | -$23K |
|
6
Meta Platforms (Facebook)
META
$1.5T
| $3.1M | 2% |
23,644
-252
| -1% | -$36.5K |
|
7
CVS Health
CVS
$134B
| $3.09M | 1.99% |
47,100
+1,814
| +4% | +$135K |
|
8
iShares US Consumer Staples ETF
IYK
$1.41B
| $2.88M | 1.85% |
81,105
-450
| -0.6% | -$17.2K |
|
9
Gilead Sciences
GILD
$163B
| $2.79M | 1.8% |
44,600
+601
| +1% | +$42K |
|
10
Biogen
BIIB
$29.8B
| $2.7M | 1.74% |
8,985
-50
| -0.6% | -$16K |
|
11
Visa
V
$683B
| $2.7M | 1.74% |
20,465
+401
| +2% | +$55.4K |
|
12
iShares Select Dividend ETF
DVY
$23.6B
| $2.45M | 1.58% |
27,400
+160
| +0.6% | +$15.3K |
|
13
iShares Russell 2000 ETF
IWM
$81.5B
| $2.4M | 1.55% |
17,940
-306
| -2% | -$45.7K |
|
14
Johnson & Johnson
JNJ
$613B
| $2.37M | 1.53% |
18,348
+885
| +5% | +$123K |
|
15
Union Pacific
UNP
$173B
| $2.35M | 1.51% |
17,006
+301
| +2% | +$44.6K |
|
|
16
Texas Pacific Land
TPL
$28B
| $2.32M | 1.49% |
38,538
+11,115
| +41% | +$801K |
|
17
iShares Core S&P Mid-Cap ETF
IJH
$124B
| $2.16M | 1.39% |
64,930
-2,175
| -3% | -$79.4K |
|
18
Iron Mountain
IRM
$36.9B
| $2.14M | 1.38% |
65,894
-2,057
| -3% | -$67.5K |
|
19
iShares Russell 1000 ETF
IWB
$49B
| $2.08M | 1.34% |
15,010
-136
| -0.9% | -$20.3K |
|
20
Vanguard Morningstar Mega Cap Growth ETF
MGK
$33.2B
| $1.93M | 1.24% |
89,990
+3,155
| +4% | +$73K |
|
21
Alphabet (Google) Class A
GOOGL
$4.57T
| $1.84M | 1.19% |
35,300
-1,220
| -3% | -$65.9K |
|
22
Berkshire Hathaway Class A
BRK.A
$1.1T
| $1.84M | 1.18% |
6
| – | – |
|
23
Golar LNG
GLNG
$5B
| $1.81M | 1.16% |
83,000
+2,300
| +3% | +$59.4K |
|
24
Philip Morris
PM
$292B
| $1.74M | 1.12% |
26,006
-6,200
| -19% | -$518K |
|
25
Medtronic
MDT
$111B
| $1.7M | 1.09% |
18,660
+97
| +0.5% | +$9.06K |
|
Similar funds
CIM
CSWM
WWP
GWM
FWM
MWS
AP
AA
Fernwood Investment Management's Q4 2018 Portfolio in Review
As of Q4 2018, Fernwood Investment Management held 174 positions worth $155M, down 18% from $189M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Fernwood Investment Management withdrew a net $6.4M in Q4 2018, closing 29 positions and reducing 64 holdings. Its most notable exit was iShares Preferred and Income Securities ETF, an estimated $841K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 29% a quarter earlier, followed by Energy and Consumer Discretionary.
Against the trend, Fernwood Investment Management opened a new position in Dayforce worth $1.39M.
- Fernwood Investment Management's largest Q4 2018 buy was Dayforce: 40,200 shares worth $1.39M.
- Fernwood Investment Management added most to Portola Pharmaceuticals, Inc. in Q4 2018, an estimated $2.28M increase.
- Fernwood Investment Management's biggest Q4 2018 reduction was Global Blood Therapeutics, Inc., cutting an estimated $993K.
- Fernwood Investment Management fully exited iShares Preferred and Income Securities ETF in Q4 2018, selling an estimated $841K.
- Fernwood Investment Management's ten largest holdings make up 33% of its $155M portfolio in Q4 2018.
- Fernwood Investment Management opened 8 new positions and closed 29 in Q4 2018.
- Fernwood Investment Management's portfolio value fell 18% quarter-over-quarter to $155M.
Based on Fernwood Investment Management's 13F filing for Q4 2018, filed 12 Feb 2019.